Julie Roupret‐Serzec

Determinants of CD19-positive vs CD19-negative relapse after tisagenlecleucel for B-cell acute lymphoblastic leukemia

Marie-Émilie Dourthe, Florence Rabian, Karima Yakouben et al. · Leukemia · 2021 · 150 citations

Medicine, Hematology, Oncology +14

Adenovirus infection and disease in paediatric haematopoietic stem cell transplant patients: clues for antiviral pre-emptive treatment

Linda Feghoul, Sylvie Chevret, Aurelie Cuinet et al. · Clinical Microbiology and Infection · 2015 · 69 citations · Full text

Medicine, Infectious Diseases, Pediatrics +14

Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia

Benoît Brethon, Élodie Lainey, Aurélie Caye‐Eude et al. · Frontiers in Oncology · 2021 · 23 citations · Full text

Medicine, Hematology, Oncology +17

Isavuconazole Treatment for Invasive Fungal Infections in Pediatric Patients

Philippe Zimmermann, Benoît Brethon, Julie Roupret‐Serzec et al. · Pharmaceuticals · 2022 · 21 citations · Full text

Medicine, Pediatrics, Pharmacotherapy +17

Safety and Efficacy of Tisagenlecleucel (CTL019) in B-Cell Acute Lymphoblastic Leukemia in Children, Adolescents and Young Adults: The French Experience

Marie-Émilie Dourthe, Florence Rabian, Karima Yakouben et al. · Blood · 2019 · 10 citations

Medicine, Hematology, Oncology +14